Reversing the Effects of Antiplatelet Agents in the Setting of Intracranial Hemorrhage: A Look at the Literature

Patients are increasingly being prescribed antiplatelet agents (APAs) for a growing number of medical and surgical conditions. These agents are associated with an increased risk of hemorrhage, including intracranial hemorrhage (ICH). In the setting of warfarin use and ICH, strategies to reverse the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of intensive care medicine 2015-01, Vol.30 (1), p.3-7
Hauptverfasser:	Jaben, Elizabeth A., Mulay, Sudhanshu B., Stubbs, James R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspirin - administration & dosage Aspirin - adverse effects Coronary Disease - drug therapy Drug Therapy, Combination Factor VIIa - therapeutic use Humans Intracranial Hemorrhages - chemically induced Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Transfusion Recombinant Proteins - therapeutic use Ticlopidine - administration & dosage Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!